 | Veracyte (NASDAQ:VCYT) Lowered to "D+" at TheStreet
marketbeat.com - May 28 at 7:11 AM |
 | Veracyte (NASDAQ:VCYT) Shares Gap Up to $35.52
americanbankingnews.com - June 10 at 12:06 PM |
 | Veracyte (NASDAQ:VCYT) - Veracyte: Return On Capital Employed Insights - Benzinga
benzinga.com - June 10 at 8:38 AM |
 | Moving Average Crossover Alert: Veracyte (VCYT) - Yahoo Finance
finance.yahoo.com - June 9 at 9:11 AM |
| Moving Average Crossover Alert: Veracyte (VCYT)
finance.yahoo.com - June 9 at 9:11 AM |
 | Form 8-K/A VERACYTE, INC. For: Jun 01 - StreetInsider.com
streetinsider.com - June 8 at 6:42 PM |
 | Veracyte: Tumultuous Times - Seeking Alpha
seekingalpha.com - June 6 at 2:04 PM |
 | Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder - Business Wire
businesswire.com - June 4 at 1:40 PM |
| Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder
finance.yahoo.com - June 4 at 1:40 PM |
| CORRECTING and REPLACING Veracyte to Present at Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - June 2 at 11:59 PM |
|
| CORRECTING and REPLACING Veracyte to Present at Upcoming Investor Conferences
finance.yahoo.com - June 2 at 6:58 PM |
 | Accenture To Buy French EPM Solutions Consulting Company Nell'Armonia; Terms Not Disclosed - Nasdaq
nasdaq.com - June 2 at 12:00 AM |
| Veracyte Strengthens Cancer Diagnostics Portfolio with HalioDx Acquisition
finance.yahoo.com - June 1 at 7:00 PM |
| Form 8-K VERACYTE, INC. For: Jun 01 - StreetInsider.com
streetinsider.com - June 1 at 1:59 PM |
| Veracyte Strengthens Cancer Diagnostics Portfolio with HalioDx Acquisition - Benzinga
benzinga.com - June 1 at 1:59 PM |
| Veracyte (NASDAQ:VCYT) Stock Price Down 5.3%
americanbankingnews.com - June 1 at 1:10 PM |
| Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth - Business Wire
businesswire.com - June 1 at 8:58 AM |
| Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
finance.yahoo.com - June 1 at 8:58 AM |
| Veracyte (NASDAQ:VCYT) Rating Reiterated by William Blair
americanbankingnews.com - May 27 at 9:08 AM |
| Veracyte to Present at Upcoming Investor Conferences - Business Wire
businesswire.com - May 26 at 6:07 PM |
| Veracyte RNA-sequencing test can aid in targeted treatments for thyroid cancer - Seeking Alpha
seekingalpha.com - May 26 at 1:06 PM |
| Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples
finance.yahoo.com - May 26 at 1:06 PM |
| Veracyte provides additional data on benefit of prostate cancer diagnostic test - Seeking Alpha
seekingalpha.com - May 25 at 12:08 PM |
| Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier
finance.yahoo.com - May 25 at 12:08 PM |
| Veracyte (NASDAQ:VCYT) Price Target Cut to $55.00
americanbankingnews.com - May 24 at 10:28 AM |
| Veracyte, Inc. (NASDAQ:VCYT) Expected to Announce Earnings of -$0.25 Per Share
americanbankingnews.com - May 23 at 11:18 AM |
| First Week of July 16th Options Trading For Veracyte (VCYT) - Nasdaq
nasdaq.com - May 21 at 2:53 PM |
| Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection - Business Wire
businesswire.com - May 19 at 7:19 PM |
|
| Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
finance.yahoo.com - May 19 at 7:19 PM |
| Veracyte (NASDAQ:VCYT) Price Target Lowered to $55.00 at Truist Securities
americanbankingnews.com - May 18 at 12:10 PM |
| Veracyte (NASDAQ:VCYT) Price Target Cut to $45.00
americanbankingnews.com - May 18 at 11:20 AM |
| Truist Cuts Veracyte (NASDAQ:VCYT) Price Target to $55.00
americanbankingnews.com - May 18 at 10:02 AM |
| Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis - Business Wire
businesswire.com - May 14 at 6:52 PM |
| Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis
finance.yahoo.com - May 14 at 6:52 PM |
| Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy - Business Wire
businesswire.com - May 14 at 1:51 PM |
| Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
finance.yahoo.com - May 14 at 1:51 PM |
| Veracyte (VCYT) Shares Cross Below Book Value - Nasdaq
nasdaq.com - May 14 at 8:51 AM |
| Veracyte Stock Is Estimated To Be Significantly Overvalued - Yahoo Finance
finance.yahoo.com - May 14 at 8:51 AM |
| A Look At The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT) - Nasdaq
nasdaq.com - May 13 at 2:50 PM |
| US$72.50: That's What Analysts Think Veracyte, Inc. (NASDAQ:VCYT) Is Worth After Its Latest Results - Yahoo Finance
finance.yahoo.com - May 13 at 2:50 PM |
| US$72.50: That's What Analysts Think Veracyte, Inc. (NASDAQ:VCYT) Is Worth After Its Latest Results
finance.yahoo.com - May 13 at 9:46 AM |
| Veracyte (NASDAQ:VCYT) - Expert Ratings for Veracyte - Benzinga
benzinga.com - May 11 at 10:49 AM |
| Veracyte Announces First Quarter 2021 Financial Results - Business Wire
businesswire.com - May 11 at 10:49 AM |
| Can the Uptrend Continue for Encore Wire Corp (WIRE)? - Nasdaq
nasdaq.com - May 11 at 12:39 AM |
| Veracyte, Inc. Announces CEO Succession Plan - Business Wire
businesswire.com - May 10 at 7:34 PM |
| Veracyte's (NASDAQ:VCYT) Wonderful 733% Share Price Increase Shows How Capitalism Can Build Wealth - Yahoo Finance
finance.yahoo.com - May 4 at 7:46 PM |
| Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress - Business Wire
businesswire.com - May 4 at 7:46 PM |
| Veracyte's (NASDAQ:VCYT) Wonderful 733% Share Price Increase Shows How Capitalism Can Build Wealth
finance.yahoo.com - May 4 at 7:46 PM |
| Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress
finance.yahoo.com - May 4 at 7:46 PM |
| Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO - Business Wire
businesswire.com - April 29 at 10:06 AM |
| Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO
finance.yahoo.com - April 29 at 10:06 AM |
